Producer | United States National Library of Medicine (United States) |
---|---|
History | 2000–present |
Access | |
Cost | Free |
Coverage | |
Disciplines | Medicine |
Record depth | Index, abstract & full-text |
Format coverage | Journal articles |
No. of records | 9,700,000 |
Links | |
Website | www |
Title list(s) | www |
PubMed Central (PMC) is a free digital repository that archives open access full-text scholarly articles that have been published in biomedical and life sciences journals. As one of the major research databases developed by the National Center for Biotechnology Information (NCBI), PubMed Central is more than a document repository. Submissions to PMC are indexed and formatted for enhanced metadata, medical ontology, and unique identifiers which enrich the XML structured data for each article. [1] Content within PMC can be linked to other NCBI databases and accessed via Entrez search and retrieval systems, further enhancing the public's ability to discover, read and build upon its biomedical knowledge. [2]
PubMed Central is distinct from PubMed. [3] PubMed Central is a free digital archive of full articles, accessible to anyone from anywhere via a web browser (with varying provisions for reuse). Conversely, although PubMed is a searchable database of biomedical citations and abstracts, the full-text article resides elsewhere (in print or online, free or behind a subscriber paywall).
As of December 2018 [update] , the PMC archive contained over 5.2 million articles, [4] with contributions coming from publishers or authors depositing their manuscripts into the repository per the NIH Public Access Policy. Earlier data shows that from January 2013 to January 2014 author-initiated deposits exceeded 103,000 papers during a 12-month period. [5] PMC identifies about 4,000 journals which participate in some capacity to deposit their published content into the PMC repository. [6] Some publishers delay the release of their articles on PubMed Central for a set time after publication, referred to as an "embargo period", ranging from a few months to a few years depending on the journal. (Embargoes of six to twelve months are the most common.) PubMed Central is a key example of "systematic external distribution by a third party", [7] which is still prohibited by the contributor agreements of many publishers.
PubMed Central began as E-biomed, initially proposed in May 1999 by then-NIH director Harold Varmus. [8] The idea came to him "abruptly" in December 1998, inspired by the early use of arXiv for preprints after a presentation from Pat Brown of Stanford and David Lipman, director of NCBI: [9] [10]
But my views broadened abruptly one morning in December of 1998 when I met Pat Brown for coffee, at the café that was formerly the famed Tassajara Bakery, on the corner of Cole and Parnassus, during a visit to San Francisco. [...] A few weeks before our coffee, Pat had learned about the methods being used by the physicist Paul Ginsparg and his colleagues at Los Alamos to allow physicists and mathematicians to share their work with one another over the Internet. They were posting "preprints" (articles not yet submitted or accepted for publication) at a publicly accessible website (called LanX or arXiv) for anyone to read and critique. [...] The more I thought about this, the more I was convinced that a radical restructuring of methods for publishing, transmitting, storing, and using biomedical research reports might be possible and beneficial. In a spirit of enthusiasm and political innocence, I wrote a lengthy manifesto, proposing the creation of an NIH-supported online system, called E-biomed.
The goal of E-biomed was to provide free access to all biomedical research. Papers submitted to E-biomed could take one of two routes: either immediately published as a preprint, or through a traditional peer review process. The peer review process was to resemble contemporary overlay journals, with an external editorial board retaining control over the process of reviewing, curating, and listing papers which would otherwise be freely accessible on the central E-biomed server. Varmus intended to realize the new possibilities presented by communicating scientific results digitally, imagining continuous conversation about published work, versioned documents, and enriched "layered" formats allowing for multiple levels of detail. [8]
The proposal to create a central index of biomedical research was a radical departure from prevailing publishing norms. Prior to the internet, publication indexes operated largely like ISBNs: allocated by registration agencies to secondary publishers. The idea that anyone could own their own address space via a domain name and create their own indexing system was a wholly new idea. [11] [12] Major commercial publishers had begun experimenting with an indexing system for scientific papers shared across publishers as early as 1993, and were spurred to action following the E-biomed proposal. At the October 1999 STM Annual Frankfurt Conference, several publishers led by Springer-Verlag reached a hurried conference room consensus to launch their competitor prototype: [13]
At the Board meeting of the STM association, held the afternoon of Monday, October 11, before the fair's Wednesday opening, discussion focused on an emerging U.S. National Library of Medicine (NLM) initiative called E-Biomed (later PubMed Central) that had been proposed by Harold Varmus of the National Institutes of Health in the spring of 1999. Varmus envisioned a digital archive of journals, accessible free of charge and with the added value of reference linking. "Our consensus was that publishers should be the ones doing the linking," said Bob Campbell, who chaired the meeting. "Since we were 'higher up the stream,' so to speak, we should be able to link our articles ahead of the NLM as part of the process of producing them. Stefan von Holtzbrinck then set the ball rolling by offering to link Nature publications with anyone else's. We decided to issue an announcement of a broad STM reference linking initiative. It was, of course, a strategic move only, since we had neither plan nor prototype."
A small group led by Arnoud de Kemp of Springer-Verlag met in an adjacent room immediately following the Board meeting to draft the announcement, which was distributed to all attendees of the STM annual meeting the following day and published in an STM membership publication. [...] The potential benefit of the service that would become CrossRef was immediately apparent. Organizations such as AIP and IOP (Institute of Physics) had begun to link to each other's publications, and the impossibility of replicating such one-off arrangements across the industry was obvious. As Tim Ingoldsby later put it, "All those linking agreements were going to kill us."
Under pressure from vigorous lobbying from commercial publishers and scientific societies who feared for lost profits, [14] NIH officials announced a revised PubMed Central proposal in August 1999. [9] PMC would receive submissions from publishers, rather than from authors as in E-biomed. Publications were allowed time-embargoed paywalls up to one year. PMC would only allow peer-reviewed work — no preprints. [15] The then-unnamed publisher-led linking system shortly thereafter became CrossRef and the larger DOI system. Varmus, Brown, and others including Michael Eisen went on to found the Public Library of Science (PLoS) in 2001, reaching the conclusion "that if we really want to change the publication of scientific research, we must do the publishing ourselves." [16]
Launched in February 2000, the repository has grown rapidly as the NIH Public Access Policy is designed to make all research funded by the National Institutes of Health (NIH) freely accessible to anyone, and, in addition, many publishers are working cooperatively with the NIH to provide free access to their works.[ citation needed ] In late 2007, the Consolidated Appropriations Act of 2008 (H.R. 2764) was signed into law and included a provision requiring the NIH to modify its policies and require inclusion into PubMed Central complete electronic copies of their peer-reviewed research and findings from NIH-funded research. These articles are required to be included within 12 months of publication. This is the first time the US government has required an agency to provide open access to research and is an evolution from the 2005 policy, in which the NIH asked researchers to voluntarily add their research to PubMed Central. [17]
A UK version of the PubMed Central system, UK PubMed Central (UKPMC), has been developed by the Wellcome Trust and the British Library as part of a nine-strong group of UK research funders. This system went live in January 2007. On 1 November 2012, it became Europe PubMed Central. The Canadian member of the PubMed Central International network, PubMed Central Canada, was launched in October 2009.
The National Library of Medicine "NLM Journal Publishing Tag Set" journal article markup language is freely available. [18] The Association of Learned and Professional Society Publishers comments that "it is likely to become the standard for preparing scholarly content for both books and journals". [19] A related DTD is available for books. [20] The Library of Congress and the British Library have announced support for the NLM DTD. [21] It has also been popular with journal service providers. [22]
With the release of public access plans for many agencies beyond NIH, PMC is in the process of becoming the repository for a wider variety of articles. [23] This includes NASA content, with the interface branded as "PubSpace". [24] [25]
Articles are sent to PubMed Central by publishers in XML or SGML, using a variety of article DTDs. Older and larger publishers may have their own established in-house DTDs, but many publishers use the NLM Journal Publishing DTD (see above).
Received articles are converted via XSLT to the very similar NLM Archiving and Interchange DTD. This process may reveal errors that are reported back to the publisher for correction. Graphics are also converted to standard formats and sizes. The original and converted forms are archived. The converted form is moved into a relational database, along with associated files for graphics, multimedia, or other associated data. Many publishers also provide PDF of their articles, and these are made available without change. [26]
Bibliographic citations are parsed and automatically linked to the relevant abstracts in PubMed, articles in PubMed Central, and resources on publishers' Web sites. PubMed links also lead to PubMed Central. Unresolvable references, such as to journals or particular articles not yet available at one of these sources, are tracked in the database and automatically come "live" when the resources become available.
An in-house indexing system provides search capability, and is aware of biological and medical terminology, such as generic vs. proprietary drug names, and alternate names for organisms, diseases and anatomical parts.
When a user accesses a journal issue, a table of contents is automatically generated by retrieving all articles, letters, editorials, etc. for that issue. When an actual item such as an article is reached, PubMed Central converts the NLM markup to HTML for delivery, and provides links to related data objects. This is feasible because the variety of incoming data has first been converted to standard DTDs and graphic formats.
In a separate submission stream, NIH-funded authors may deposit articles into PubMed Central using the NIH Manuscript Submission (NIHMS). Articles thus submitted typically go through XML markup in order to be converted to NLM DTD.
Reactions to PubMed Central among the scholarly publishing community range between a genuine enthusiasm by some, [27] to cautious concern by others. [28]
While PMC is a welcome partner to open access publishers in its ability to augment the discovery and dissemination of biomedical knowledge, that same truth causes others to worry about traffic being diverted from the published version of record, the economic consequences of less readership, as well as the effect on maintaining a community of scholars within learned societies. [29] [30] A 2013 analysis found strong evidence that public repositories of published articles were responsible for "drawing significant numbers of readers away from journal websites" and that "the effect of PMC is growing over time". [30]
Libraries, universities, open access supporters, consumer health advocacy groups, and patient rights organizations have applauded PubMed Central, and hope to see similar public access repositories developed by other federal funding agencies so to freely share any research publications that were the result of taxpayer support. [31]
The Antelman study of open access publishing found that in philosophy, political science, electrical and electronic engineering and mathematics, open access papers had a greater research impact. [32] A randomised trial found an increase in content downloads of open access papers, with no citation advantage over subscription access one year after publication. [33]
The NIH policy and open access repository work has inspired a 2013 presidential directive which has sparked action in other federal agencies as well.
In March 2020, PubMed Central accelerated its deposit procedures for the full text of publications on coronavirus. The NLM did so upon request from the White House Office of Science and Technology Policy and international scientists to improve access for scientists, healthcare providers, data mining innovators, AI healthcare researchers, and the general public. [34]
The PMCID (PubMed Central identifier), also known as the PMC reference number, is a bibliographic identifier for the PubMed Central open access database, much like the PMID is the bibliographic identifier for the PubMed database. The two identifiers are distinct however. It consists of "PMC" followed by a string of numbers. The format is: [35]
Authors applying for NIH awards must include the PMCID in their application.
MEDLINE is a bibliographic database of life sciences and biomedical information. It includes bibliographic information for articles from academic journals covering medicine, nursing, pharmacy, dentistry, veterinary medicine, and health care. MEDLINE also covers much of the literature in biology and biochemistry, as well as fields such as molecular evolution.
The United States National Library of Medicine (NLM), operated by the United States federal government, is the world's largest medical library.
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.
PubMed is a free database including primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine (NLM) at the National Institutes of Health maintains the database as part of the Entrez system of information retrieval.
The Entrez Global Query Cross-Database Search System is a federated search engine, or web portal that allows users to search many discrete health sciences databases at the National Center for Biotechnology Information (NCBI) website. The NCBI is a part of the National Library of Medicine (NLM), which is itself a department of the National Institutes of Health (NIH), which in turn is a part of the United States Department of Health and Human Services. The name "Entrez" was chosen to reflect the spirit of welcoming the public to search the content available from the NLM.
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
SciELO is a bibliographic database, digital library, and cooperative electronic publishing model of open access journals. SciELO was created to meet the scientific communication needs of developing countries and provides an efficient way to increase visibility and access to scientific literature. Originally established in Brazil in 1997, today there are 16 countries in the SciELO network and its journal collections: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, Mexico, Paraguay, Peru, Portugal, South Africa, Spain, Uruguay, and Venezuela.
David J. Lipman is an American biologist who from 1989 to 2017 was the director of the National Center for Biotechnology Information (NCBI) at the National Institutes of Health. NCBI is the home of GenBank, the U.S. node of the International Sequence Database Consortium, and PubMed, one of the most heavily used sites in the world for the search and retrieval of biomedical information. Lipman is one of the original authors of the BLAST sequence alignment program, and a respected figure in bioinformatics. In 2017, he left NCBI and became Chief Science Officer at Impossible Foods.
The Vancouver system, also known as Vancouver reference style or the author–number system, is a citation style that uses numbers within the text that refer to numbered entries in the reference list. It is popular in the physical sciences and is one of two referencing systems normally used in medicine, the other being the author–date, or "Harvard", system. Vancouver style is used by MEDLINE and PubMed.
Index Medicus (IM) is a curated subset of MEDLINE, which is a bibliographic database of life science and biomedical science information, principally scientific journal articles. From 1879 to 2004, Index Medicus was a comprehensive bibliographic index of such articles in the form of a print index or its onscreen equivalent. Medical history experts have said of Index Medicus that it is “America's greatest contribution to medical knowledge.”
Europe PubMed Central is an open-access repository that contains millions of biomedical research works. It was known as UK PubMed Central until 1 November 2012.
The Redalyc project is a bibliographic database and a digital library of Open Access journals, supported by the Universidad Autónoma del Estado de México with the help of numerous other higher education institutions and information systems.
PubMed Central Canada was a Canadian national digital repository of peer-reviewed health and life sciences literature. It operated from 2010 to 2018. It joined Europe PubMed Central as a member of the PubMed Central International network. PMC Canada was a partnership between the Canadian Institutes of Health Research (CIHR), the Canada Institute for Scientific and Technical Information, and the United States National Library of Medicine (NLM).
Elizabeth Marincola is the Senior Advisor for Communications and Advocacy at the African Academy of Sciences and is responsible for AAS Open Research, the Academy’s publishing platform. She has advocated for increased government resources dedicated to science and improved public education in science, and is an advocate of open access to the scientific literature, open scholarship and advancing research communication. Her 2013 TEDMED talk addresses many issues facing science, technology and medicine (STM) publishers, and she has advocated for quality research in Africa and why it is important. She also serves as an Ambassador for the European Science Foundation's Plan S.
An open-access mandate is a policy adopted by a research institution, research funder, or government which requires or recommends researchers—usually university faculty or research staff and/or research grant recipients—to make their published, peer-reviewed journal articles and conference papers open access (1) by self-archiving their final, peer-reviewed drafts in a freely accessible institutional repository or disciplinary repository or (2) by publishing them in an open-access journal or both.
The NIH Public Access Policy is an open access mandate, drafted in 2004 and mandated in 2008, requiring that research papers describing research funded by the National Institutes of Health must be available to the public free through PubMed Central within 12 months of publication. PubMed Central is the self-archiving repository in which authors or their publishers deposit their publications. Copyright is retained by the usual holders, but authors may submit papers with one of the Creative Commons licenses.
The Journal Article Tag Suite (JATS) is an XML format used to describe scientific literature published online. It is a technical standard developed by the National Information Standards Organization (NISO) and approved by the American National Standards Institute with the code Z39.96-2012.
Epigenetics & Chromatin is a peer-reviewed open access scientific journal published by BioMed Central that covers the biology of epigenetics and chromatin.
GigaScience is a peer-reviewed scientific journal that was established in 2012. It covers research and large data-sets that result from work in the biomedical and life sciences. The editor-in-chief is Scott Edmunds. Originally, the journal was co-published by BioMed Central and the Beijing Genomics Institute (BGI). In 2016, it left BioMed Central to form a new partnership between the GigaScience Press department of BGI and Oxford University Press. In 2018, GigaScience won the Association of American Publishers' PROSE Award for Innovation in journal publishing in the multidisciplinary category.
The idea and practise of providing free online access to journal articles began at least a decade before the term "open access" was formally coined. Computer scientists had been self-archiving in anonymous ftp archives since the 1970s and physicists had been self-archiving in arXiv since the 1990s. The Subversive Proposal to generalize the practice was posted in 1994.
To support this initiative, NLM is adapting its standard procedures for depositing articles into PMC to provide greater flexibility that will ensure coronavirus research is readily available.